Document is current
Any future updates will be listed below
-
Authors
Garneau, William M.
Wang, Kunbo
Liang, Tao
Xu, Yanxun
Gladstone, Douglas E.
Avery, Robin K.
D’Alessio, Franco R.
Robinson, Matthew L.
Sahetya, Sarina K.
Garibaldi, Brian T.
Gebo, Kelly A.
Dioverti, M. Veronica
-
Funding
Funding for this research was provided by:
Johns Hopkins in Health
National Heart, Lung, and Blood Institute (R01HL131812, K23HL155507)
Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases
U.S. Food and Drug Administration (2U18FD005320)
National Institute of Biomedical Imaging and Bioengineering (U54EB007958)
Parker B. Francis Foundation
Johns Hopkins University COVID-19 Research Response Program
- License Information
-
More Information
Article History
Received: 4 September 2024
Accepted: 11 March 2025
First Online: 20 March 2025
Declarations
:
: The authors declare no competing interests.
: The study was performed in accordance with the Declaration of Helsinki and was approved under protocol IRB00283579 by the Johns Hopkins University School of Medicine Institutional Review Board. The need to obtain informed consent was waived by the Johns Hopkins University School of Medicine Institutional Review Board.
: Due to the retrospective nature of the study, Johns Hopkins University School of Medicine Institutional Review Board waived the need of obtaining informed consent. Data for the study publication was obtained from protocol IRB00247569 which maintains current IRB approval and was included under a waiver of consent.
